Abstract
Toll-like receptors (TLRs) and NK cell receptors are the most important receptor superfamilies in innate immunity. TLRs act as the sensor of external pathogens, while NK cells detect alterations in endogenous protein expression on target cells through activating and inhibitory receptors. Accumulating data has demonstrated that TLRs and NK cell receptors can coordinate and regulate each other during immune responses, which contributes to the initiation of innate response and the priming of adaptive responses. TLRs can activate NK cell function directly or with the help of accessory cells in a cytokine or cell-to-cell contact dependent manner. More understanding of the recognition of innate receptors and interactions between them may provide important insights into the design of effective strategies to combat tumor and microbial infections. In this review, we summarize how TLRs and NK cells discriminate the self or non-self components respectively. And importantly, we pay more attention to the role of TLR signaling in induction of NK cell activation, responses and the crosstalk between them.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol, 2010, 11: 373–384
Janeway C A Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol, 2002, 20: 197–216
Pisegna S, Pirozzi G, Piccoli M, et al. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood, 2004, 104: 4157–4164
Yoneyama M, Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev, 2009, 227: 54–65
Raulet D H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol, 2004, 5: 996–1002
Colonna M, Jonjic S, Watzl C. Natural killer cells: Fighting viruses and much more. Nat Immunol, 2011, 12: 107–110
Tu Z K, Bozorgzadeh A, Pierce R H, et al. TLR-dependent cross talk between human Kupfer cells and NK cells. J Exp Med, 2008, 205: 233–244
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell, 2006, 124: 783–801
Pukkila-Worley R, Ausubel F M. Immune defense mechanisms in the Caenorhabditis elegans intestinal epithelium. Curr Opin Immunol, 2012, 24: 3–9
Pietrocola G, Arciola C R, Rindi S, et al. Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus. Int J Artif Organs, 2011, 34: 799–810
Jin M S, Lee J O. Structures of the Toll-like receptor family and its ligand complexes. Immunity, 2008, 29: 182–191
Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity, 2011, 34: 637–650
Thompson M R, Kaminski J J, Kurt-Jones E A, et al. Pattern recognition receptors and the innate immune response to viral infection. Viruses, 2011, 3: 920–940
Blasius A L, Beutler B. Intracellular Toll-like receptors. Immunity, 2010, 32: 305–315
Barbalat R, Ewald S E, Mouchess M L, et al. Nucleic acid recognition by the innate immune system. Annu Rev Immunol, 2011, 29: 185–214
Akashi-Takamura S, Miyake K. TLR accessory molecules. Curr Opin Immunol, 2008, 20: 420–425
Oeckinghaus A, Hayden M S, Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat Immunol, 2011, 12: 695–708
Anand P K, Tait S W, Lamkanfi M, et al. TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation. J Biol Chem, 2011, 286: 42981–42991
Hoebe K, Georgel P, Rutschmann S, et al. CD36 is a sensor of diacylglycerides. Nature, 2005, 433: 523–527
Goodridge H S, Underhill D M. Fungal recognition by TLR2 and Dectin-1. Handb Exp Pharmacol, 2008, 183: 87–109
Yang R B, Mark M R, Gurney A L. Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2. J Immunol, 1999, 163: 639–643
Yan N, Chen Z J. Intrinsic antiviral immunity. Nat Immunol, 2012, 13: 214–222
O’Neill L A, Bowie A G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol, 2007, 7: 353–364
Yamamoto M, Takeda K. Current views of Toll-like receptor signaling pathways. Gastroenterol Res Pract, 2010, 2010: 240365
Sun J C, Lanier L L. NK cell development, homeostasis and function: Parallels with CD8 T cells. Nat Rev Immunol, 2011, 11: 645–657
Raulet D H, Vance R E. Self-tolerance of natural killer cells. Nat Rev Immunol, 2006, 6: 520–531
Raulet D H. Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol, 2006, 18: 145–150
Huntington N D, Vosshenrich C A, Di Santo J P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol, 2007, 7: 703–714
Leavy O. Maturation and function of NK cells. Nat Rev Immunol, 2012, 12: 150–151
Thielens A, Vivier E, Romagne F. NK cell MHC class I specific receptors (KIR): From biology to clinical intervention. Curr Opin Immunol, 2012, 24: 239–245
Orr M T, Lanier L L. Inhibitory Ly49 receptors on mouse natural killer cells. Curr Top Microbiol Immunol, 2011, 350: 67–87
Vivier E, Romagne F. Good news, bad news for missing-self recognition by NK cells: Autoimmune control but viral evasion. Immunity, 2007, 26: 549–551
Lanier L L. NK cell recognition. Annu Rev Immunol, 2005, 23: 225–274
Sullivan L C, Clements C S, Rossjohn J, et al. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens, 2008, 72: 415–424
Vivier E, Tomasello E, Baratin M, et al. Functions of natural killer cells. Nat Immunol, 2008, 9: 503–510
Zloza A, Kohlhapp F J, Lyons G E, et al. NKG2D signaling on CD8(+) T cells represses T-bet and rescues CD4-unhelped CD8(+) T cell memory recall but not effector responses. Nat Med, 2012, 18: 422–428
Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 1999, 285: 727–729
Raulet D H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol, 2003, 3: 781–790
Cosman D, Mullberg J, Sutherland C L, et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity, 2001, 14: 123–133
Huang B, Sikorski R, Sampath P, et al. Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer. J Immunother, 2011, 34: 289–296
Turnbull I R, Colonna M. Activating and inhibitory functions of DAP12. Nat Rev Immunol, 2007, 7: 155–161
Lauzon N M, Mian F, MacKenzie R, et al. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol, 2006, 241: 102–112
Pisegna S, Pirozzi G, Piccoli M, et al. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood, 2004, 104: 4157–4164
Schmidt K N, Leung B, Kwong M, et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol, 2004, 172: 138–143
Duluc D, Tan F, Scotet M, et al. PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta. Eur J Immunol, 2009, 39: 2877–2884
Xie L, Pries R, Kesselring R, et al. Head and neck cancer triggers the internalization of TLR3 in natural killer cells. Int J Mol Med, 2007, 20: 493–499
Tabeta K, Georgel P, Janssen E, et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA, 2004, 101: 3516–3521
Gorski K S, Waller E L, Bjornton-Severson J, et al. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int Immunol, 2006, 18: 1115–1126
Hart O M, Athie-Morales V, O’Connor G M, et al. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol, 2005, 175: 1636–1642
Girart M V, Fuertes M B, Domaica C I, et al. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J Immunol, 2007, 179: 3472–3479
Lester R T, Yao X D, Ball T B, et al. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS, 2008, 22: 685–694
Alter G, Suscovich T J, Teigen N, et al. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J Immunol, 2007, 178: 7658–7666
Pries R, Wulff S, Kesselring R, et al. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7. Int J Oncol, 2008, 33: 993–1000
Lu H, Dietsch G N, Matthews M A, et al. VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. Clin Cancer Res, 2012, 18: 499–509
Shojaei H, Oberg H H, Juricke M, et al. Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells. Cancer Res, 2009, 69: 8710–8717
Ma F, Zhang J, Zhang J, et al. The TLR-7 agonists, imiquimod and gardiquimod, improve DC-based immunotherapy for melanoma in mice. Cell Mol Immunol, 2010, 7: 381–388
Vollmer J, Weeratna R, Payette P, et al. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol, 2004, 34: 251–262
Sivori S, Carlomagno S, Moretta L, et al. Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells. Eur J Immunol, 2006, 36: 961–967
Schleicher U, Liese J, Knippertz I, et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med, 2007, 204: 893–906
Takeshita F, Leifer C A, Gursel I, et al. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol, 2001, 167: 3555–3558
Krieg A M. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene, 2008, 27: 161–167
Hamzah J, Altin J G, Herringson T, et al. Targeted liposomal delivery of TLR9 ligands activates spontaneous antitumor immunity in an autochthonous cancer model. J Immunol, 2009, 183: 1091–1098
Geary S M, Lemke C D, Lubaro V D M, et al. Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN. Cancer Immunol Immunother, 2011, 60: 1309–1317
Lima G K, Zolini G P, Mansur D S, et al. Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection. Am J Pathol, 2010, 177: 2433–2445
Liese J, Schleicher U, Bogdan C. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur J Immunol, 2007, 37: 3424–3434
Carvalho L P, Petritus P M, Trochtenberg A L, et al. Lymph node hypertrophy following Leishmania major infection is dependent on TLR9. J Immunol, 2012, 34: 1394–1401
Rozy A, Chorostowska-Wynimko J. Bacterial immunostimulants—Mechanism of action and clinical application in respiratory diseases. Pneumonol Alergol Pol, 2008, 76: 353–359
Chalifour A, Jeannin P, Gauchat J F, et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers-defensin production. Blood, 2004, 104: 1778–1783
Lindgren A, Pavlovic V, Flach C F, et al. Interferon-gamma secretion is induced in IL-12 stimulated human NK cells by recognition of Helicobacter pylori or TLR2 ligands. Innate Immun, 2011, 17: 191–203
Martinez J, Huang X, Yang Y. Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog, 2010, 6: e1000811
Lu H, Yang Y, Gad E, et al. TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clin Cancer Res, 2011, 17: 6742–6753
Mian M F, Lauzon N M, Andrews D W, et al. FimH can directly activate human and murine natural killer cells via TLR4. Mol Ther, 2010, 18: 1379–1388
Dong Z, Wei H, Sun R, et al. Involvement of natural killer cells in PolyI:C-induced liver injury. J Hepatol, 2004, 41: 966–973
Wang J, Xu J, Zhang W, et al. TLR3 ligand-induced accumulation of activated splenic natural killer cells into liver. Cell Mol Immunol, 2005, 2: 449–453
Wang J, Sun R, Wei H, et al. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates Toll-like receptor-3 ligand-induced NK cell-mediated liver injury. Int Immunopharmacol, 2006, 6: 800–807
Chen Y, Wei H, Sun R, et al. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology, 2007, 46: 706–715
Chen Y, Sun R, Jiang W, et al. Liver-specific HBsAg transgenic mice are over-sensitive to poly(I:C)-induced liver injury in NK cell- and IFN-gamma-dependent manner. J Hepatol, 2007, 47: 183–190
Shimoda S, Harada K, Niiro H, et al. Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis. Hepatology, 2011, 53: 1270–1281
Zhang J, Sun R, Wei H, et al. Toll-like receptor 3 agonist enhances IFN-gamma and TNF-alpha production by murine uterine NK cells. Int Immunopharmacol, 2007, 7: 588–596
Sivori S, Falco M, Carlomagno S, et al. A novel KIR-associated function: Evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2. Blood, 2010, 116: 1637–1647
Sivori S, Falco M, Moretta L, et al. Extending killer Ig-like receptor function: From HLA class I recognition to sensors of microbial products. Trends Immunol, 2010, 31: 289–294
Lodoen M B, Lanier L L. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol, 2006, 18: 391–398
Guerra C, Johal K, Morris D, et al. Control of Mycobacterium tuberculosis growth by activated natural killer cells. Clin Exp Immunol, 2012, 168: 142–152
Vankayalapati R, Garg A, Porgador A, et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol, 2005, 175: 4611–4617
Eissmann P, Evans J H, Mehrabi M, et al. Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol, 2010, 184: 6901–6909
Zhou Z, Zhang C, Zhang J, et al. Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1. PLoS ONE, 2012, 7: e36928
Kloss M, Decker P, Baltz K M, et al. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of NKG2D ligand MICA. J Immunol, 2008, 181: 6711–6719
Hou X, Zhou R, Wei H, et al. NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hepatology, 2009, 49: 940–949
Radaeva S, Sun R, Jaruga B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology, 2006, 130: 435–452
Schreiner B, Voss J, Wischhusen J, et al. Expression of Toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB J, 2006, 20: 118–120
Champsaur M, Lanier L L. Effect of NKG2D ligand expression on host immune responses. Immunol Rev, 2010, 235: 267–285
Zhou R, Wei H, Sun R, et al. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc Natl Acad Sci USA, 2007, 104: 7512–7515
Wu H, Chen G, Wyburn K R, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest, 2007, 117: 2847–2859
Shigeoka A A, Holscher T D, King A J, et al. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol, 2007, 178: 6252–6258
Cooper M A, Fehniger T A, Fuchs A, et al. NK cell and DC interactions. Trends Immunol, 2004, 25: 47–52
Reizis B, Colonna M, Trinchieri G, et al. Plasmacytoid dendritic cells: One-trick ponies or workhorses of the immune system? Nat Rev Immunol, 2011, 11: 558–565
Romagnani C, Della C M, Kohler S, et al. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur J Immunol, 2005, 35: 2452–2458
Swiecki M, Gilfillan S, Vermi W, et al. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity, 2010, 33: 955–966
Persson C M, Chambers B J. Plasmacytoid dendritic cell-induced migration and activation of NK cells in vivo. Eur J Immunol, 2010, 40: 2155–2164
Zanoni I, Granucci F. Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors. J Mol Med (Berl), 2010, 88: 873–880
Miyake T, Kumagai Y, Kato H, et al. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways. J Immunol, 2009, 183: 2522–2528
Vulink A, Radford K J, Melief C, et al. Dendritic cells in cancer immunotherapy. Adv Cancer Res, 2008, 99: 363–407
Romani N, Gruner S, Brang D. Proliferating dendritic cell progenitors in human blood. J Exp Med, 1994, 180: 83–93
Seya T, Kasamatsu J, Azuma M, et al. Natural killer cell activation secondary to innate pattern sensing. J Innate Immun, 2011, 3: 264–273
McCartney S, Vermi W, Gilfillan S, et al. Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J Exp Med, 2009, 206: 2967–2976
Ebihara T, Azuma M, Oshiumi H, et al. Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation. J Exp Med, 2010, 207: 2675–2687
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Guo, Q., Zhang, C. Critical role of Toll-like receptor signaling in NK cell activation. Chin. Sci. Bull. 57, 3192–3202 (2012). https://doi.org/10.1007/s11434-012-5257-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-012-5257-1